286 related articles for article (PubMed ID: 30971426)
41. Biochemical screening assays to identify HIV-1 integrase inhibitors.
Clynhens M; Smets A; Vereycken I; Van Loock M; Clayton R; Meersseman G; Goethals O
Methods Mol Biol; 2013; 1030():25-36. PubMed ID: 23821258
[TBL] [Abstract][Full Text] [Related]
42. Monitoring the HIV-1 integrase enzymatic activity using atomic force microscopy in a 2LTR system.
Guy S; Rotem D; Hayouka Z; Gabizon R; Levin A; Zemel L; Loyter A; Porath D; Friedler A
Chem Commun (Camb); 2013 Apr; 49(30):3113-5. PubMed ID: 23463374
[TBL] [Abstract][Full Text] [Related]
43. Mapping target site selection for the non-specific nuclease activities of retroviral integrase.
Katzman M; Sudol M; Pufnock JS; Zeto S; Skinner LM
Virus Res; 2000 Jan; 66(1):87-100. PubMed ID: 10653920
[TBL] [Abstract][Full Text] [Related]
44. The lethal phenotype observed after HIV-1 integrase expression in yeast cells is related to DNA repair and recombination events.
Parissi V; Caumont A; de Soultrait VR; Desjobert C; Calmels C; Fournier M; Gourgue G; Bonneu M; Tarrago-Litvak L; Litvak S
Gene; 2003 Dec; 322():157-68. PubMed ID: 14644507
[TBL] [Abstract][Full Text] [Related]
45. Analysis of NCp7-dependent activation of HIV-1 cDNA integration and its conservation among retroviral nucleocapsid proteins.
Poljak L; Batson SM; Ficheux D; Roques BP; Darlix JL; Käs E
J Mol Biol; 2003 Jun; 329(3):411-21. PubMed ID: 12767826
[TBL] [Abstract][Full Text] [Related]
46. Correlation of recombinant integrase activity and functional preintegration complex formation during acute infection by replication-defective integrase mutant human immunodeficiency virus.
Li X; Koh Y; Engelman A
J Virol; 2012 Apr; 86(7):3861-79. PubMed ID: 22278243
[TBL] [Abstract][Full Text] [Related]
47. Interaction of HIV-1 integrase with polypyrimidine tract binding protein and associated splicing factor (PSF) and its impact on HIV-1 replication.
Yadav P; Sur S; Desai D; Kulkarni S; Sharma V; Tandon V
Retrovirology; 2019 Apr; 16(1):12. PubMed ID: 31036027
[TBL] [Abstract][Full Text] [Related]
48. Two bases are deleted from the termini of HIV-1 linear DNA during integrative recombination.
Pauza CD
Virology; 1990 Dec; 179(2):886-9. PubMed ID: 2238479
[TBL] [Abstract][Full Text] [Related]
49. Quantitative analysis of HIV-1 preintegration complexes.
Engelman A; Oztop I; Vandegraaff N; Raghavendra NK
Methods; 2009 Apr; 47(4):283-90. PubMed ID: 19233280
[TBL] [Abstract][Full Text] [Related]
50. Processing of viral DNA ends channels the HIV-1 integration reaction to concerted integration.
Li M; Craigie R
J Biol Chem; 2005 Aug; 280(32):29334-9. PubMed ID: 15958388
[TBL] [Abstract][Full Text] [Related]
51. Chromosomal integration of LTR-flanked DNA in yeast expressing HIV-1 integrase: down regulation by RAD51.
Desfarges S; San Filippo J; Fournier M; Calmels C; Caumont-Sarcos A; Litvak S; Sung P; Parissi V
Nucleic Acids Res; 2006; 34(21):6215-24. PubMed ID: 17090598
[TBL] [Abstract][Full Text] [Related]
52. Fusion proteins consisting of human immunodeficiency virus type 1 integrase and the designed polydactyl zinc finger protein E2C direct integration of viral DNA into specific sites.
Tan W; Zhu K; Segal DJ; Barbas CF; Chow SA
J Virol; 2004 Feb; 78(3):1301-13. PubMed ID: 14722285
[TBL] [Abstract][Full Text] [Related]
53. Identification of critical amino acid residues in human immunodeficiency virus type 1 IN required for efficient proviral DNA formation at steps prior to integration in dividing and nondividing cells.
Tsurutani N; Kubo M; Maeda Y; Ohashi T; Yamamoto N; Kannagi M; Masuda T
J Virol; 2000 May; 74(10):4795-806. PubMed ID: 10775618
[TBL] [Abstract][Full Text] [Related]
54. Treatment with suboptimal doses of raltegravir leads to aberrant HIV-1 integrations.
Varadarajan J; McWilliams MJ; Hughes SH
Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14747-52. PubMed ID: 23959861
[TBL] [Abstract][Full Text] [Related]
55. Inhibitory effect of the polyanionic drug suramin on the in vitro HIV DNA integration reaction.
Carteau S; Mouscadet JF; Goulaouic H; Subra F; Auclair C
Arch Biochem Biophys; 1993 Sep; 305(2):606-10. PubMed ID: 8373200
[TBL] [Abstract][Full Text] [Related]
56. Contribution of the C-terminal tri-lysine regions of human immunodeficiency virus type 1 integrase for efficient reverse transcription and viral DNA nuclear import.
Ao Z; Fowke KR; Cohen EA; Yao X
Retrovirology; 2005 Oct; 2():62. PubMed ID: 16232319
[TBL] [Abstract][Full Text] [Related]
57. Human immunodeficiency virus type 1 2-LTR circles reside in a nucleoprotein complex which is different from the preintegration complex.
Bukrinsky M; Sharova N; Stevenson M
J Virol; 1993 Nov; 67(11):6863-5. PubMed ID: 8411390
[TBL] [Abstract][Full Text] [Related]
58. Time course of total HIV-1 DNA and 2-long-terminal repeat circles in patients with controlled plasma viremia switching to a raltegravir-containing regimen.
Delaugerre C; Charreau I; Braun J; Néré ML; de Castro N; Yeni P; Ghosn J; Aboulker JP; Molina JM; Simon F;
AIDS; 2010 Sep; 24(15):2391-5. PubMed ID: 20683319
[TBL] [Abstract][Full Text] [Related]
59. Human immunodeficiency virus type 1 integrase: effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells.
Wiskerchen M; Muesing MA
J Virol; 1995 Jan; 69(1):376-86. PubMed ID: 7983732
[TBL] [Abstract][Full Text] [Related]
60. Probing of HIV-1 integrase/DNA interactions using novel analogs of viral DNA.
Agapkina J; Smolov M; Barbe S; Zubin E; Zatsepin T; Deprez E; Le Bret M; Mouscadet JF; Gottikh M
J Biol Chem; 2006 Apr; 281(17):11530-40. PubMed ID: 16500899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
